Porton Fine Chemicals, a China-based contract development and manufacturing organization (CDMO), has launched Porton USA’s Technology Center based in Cranbury, NJ, which will serve the U.S. biopharmaceutical industry, offering drug development and cross-lifecycle research, development and manufacturing solutions. The company says it aims to deliver solutions on complex synthetic routes, next-generation processes and assembly of specialized molecules such as highly potent advanced interm...